Chemist specialised in molecular cardiology and studying the molecular regulation of heart remodelling, heart failure, and inherited cardiomyopathies. Specialised in cell signalling, gene therapy, transcriptional and post-transcriptional regulation, and animal models of heart disease. Group leader at CNIC since 2009.
